2000
DOI: 10.1016/s0027-5107(00)00076-2
|View full text |Cite
|
Sign up to set email alerts
|

The bacterial tryptophan reverse mutation assay with Escherichia coli WP2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
83
0
2

Year Published

2009
2009
2023
2023

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 112 publications
(86 citation statements)
references
References 28 publications
1
83
0
2
Order By: Relevance
“…38 It should also be noted that our system is compatible with the genome-borne Trp system and the F′-borne LacZ reversion system. 15,16,42 This compatibility provides unique opportunities to independently measure the mutational events in genomes and plasmids, which is especially useful when searching for genome-specific or plasmid-specific mutagenic factors.…”
Section: Discussionmentioning
confidence: 99%
“…38 It should also be noted that our system is compatible with the genome-borne Trp system and the F′-borne LacZ reversion system. 15,16,42 This compatibility provides unique opportunities to independently measure the mutational events in genomes and plasmids, which is especially useful when searching for genome-specific or plasmid-specific mutagenic factors.…”
Section: Discussionmentioning
confidence: 99%
“…The number of revertant (His+) mutant colonies after exposure with a potential carcinogen can be determined. A similar test utilizing Escherichia coli and a tryptophan synthesis reverse mutation is also commonly applied and approved by the OECD (guideline T472) [105,106]. Such tests are often applied as a preliminary test for potential carcinogenicity of substances.…”
Section: Specific Endpoints 321 Mutagenesis and Carcinogenicitymentioning
confidence: 99%
“…The E. coli WP2 (uvrA) strain carries a mutation at the tryptophan (trp) allele, which is an auxotrophic mutation reverted by base-pair substitution. The strain is deficient in the repair of UV-induced DNA damage (uvrA) (Bridges, 1972;Green and Muriel, 1976;Mortelmans and Riccio, 2000) and thus has enhanced sensitivity to some mutagenic agents.…”
Section: Test Systemmentioning
confidence: 99%